3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Cyclophosphamide
32
Vincristine
22
blinatumomab
20
Methotrexate
20
Specimen Handling
19
Prednisone
19
Cytarabine
17
merphos
16
prednylidene
15
deltacortene
15
Biopsy
15
Mercaptopurine
14
Doxorubicin
14
Dexamethasone
14
N,N-dicyclohexyl-isoborneol-10-sulfonamide
13
pegaspargase
12
azathiopurine
12
Rituximab
12
Etoposide
12
dexamethasone acetate
11
dexamethasone 21-phosphate
11
auricularum
11
Spinal Puncture
11
Calcium Dobesilate
11
Asparaginase
11
Leucovorin
10
fludarabine
9
Magnetic Resonance Spectroscopy
9
Inotuzumab Ozogamicin
9
Daunorubicin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Watchful Waiting
×
90 days
×
Clear all
No trials found.